Growth Metrics

Biodesix (BDSX) Return on Capital Employed (2020 - 2025)

Biodesix (BDSX) has disclosed Return on Capital Employed for 6 consecutive years, with 0.39% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.39%, compared with a TTM value of 0.39% through Dec 2025, up 1.0%, and an annual FY2025 reading of 0.37%, up 4.0% over the prior year.
  • Return on Capital Employed was 0.39% for Q4 2025 at Biodesix, up from 0.46% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.2% in Q1 2021 and bottomed at 1.52% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.69%, with a median of 0.53% recorded in 2025.
  • The sharpest move saw Return on Capital Employed crashed -115bps in 2022, then surged 62bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.76% in 2021, then dropped by -21bps to 0.92% in 2022, then rose by 24bps to 0.69% in 2023, then surged by 42bps to 0.4% in 2024, then grew by 2bps to 0.39% in 2025.
  • Business Quant data shows Return on Capital Employed for BDSX at 0.39% in Q4 2025, 0.46% in Q3 2025, and 0.47% in Q2 2025.